Healthcare

Despite posting disappointing quarterly results and facing continued share price pressure, market analysts are demonstrating notable optimism toward CareDx. The...

The U.S. Food and Drug Administration (FDA) has launched a significant regulatory action, placing telehealth company Hims & Hers under...

Biopharmaceutical company Incyte may be on the verge of a significant advancement for its dermatology division. New long-term results for...

Eli Lilly has delivered a decisive victory in a head-to-head clinical trial against competitor Novo Nordisk, with results exceeding market...

As Alight shares touch new annual lows, an unexpected strategic partnership with digital health firm Sword Health has emerged as...

While market headlines often focus on technology giants, a significant transformation is unfolding within the healthcare diagnostics sector. Quest Diagnostics,...

Global alternative asset manager TPG is actively pursuing major acquisitions across multiple sectors, demonstrating its aggressive growth strategy. The firm...

Embecta, a specialized diabetes care company, is currently presenting investors with a puzzling dichotomy. Despite posting solid quarterly figures and...

Huron Consulting Group has delivered a powerful demonstration of growth in its second quarter 2025 results, prompting a significant upward...

Deciphera Pharmaceuticals has achieved a pivotal regulatory victory with the European Commission granting marketing authorization for its drug ROMVIMZA™. The...